During the past decade, PRA Health Sciences conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PRA Health Sciences" #1 sponsor was "Bristol-Myers Squibb" with 8 trials, followed by "AcelRx Pharmaceuticals, Inc." with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PRA Health Sciences" #1 collaborator was "DynPort Vaccine Company LLC, A GDIT Company" with 2 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "PRA Health Sciences" are "Healthy Participants" (6 trials), "Healthy" (5 trials), "Healthy Volunteers" (4 trials), "Pharmacokinetics" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "PRA Health Sciences" in a lesser frequency.

Most popular intervention types in "PRA Health Sciences" are "Drug" (29 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (3 trials), "Placebo: Normal saline" (2 trials), "SUVN-D4010" (2 trials) and "40 consecutive doses of SUF NT 15 mcg taken every 20 minutes" (1 trials). Other intervention names were less common.

The vast majority of trials in "PRA Health Sciences" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "PRA Health Sciences". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in PRA Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PRA Health Sciences, 29 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".